Amedisys, Inc. (AMED)
NASDAQ: AMED · IEX Real-Time Price · USD
97.60
-0.13 (-0.13%)
At close: Jul 19, 2024, 4:00 PM
97.52
-0.08 (-0.08%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Amedisys Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Amedisys stock have an average target of 100.75, with a low estimate of 100 and a high estimate of 101. The average target predicts an increase of 3.23% from the current stock price of 97.60.
Analyst Consensus: Hold
* Price targets were last updated on Apr 25, 2024.
Analyst Ratings
The average analyst rating for Amedisys stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 1 | 1 | 1 | 1 | 1 |
| Hold | 10 | 9 | 9 | 9 | 9 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 10 | 10 | 10 | 10 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jul 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +3.48% | Apr 25, 2024 |
| Raymond James | Raymond James | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 26, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $97 → $100 | Buy | Maintains | $97 → $100 | +2.46% | Mar 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $100 → $101 | Hold | Maintains | $100 → $101 | +3.48% | Sep 14, 2023 |
Financial Forecast
Revenue This Year
2.38B
from 2.24B
Increased by 6.29%
Revenue Next Year
2.51B
from 2.38B
Increased by 5.72%
EPS This Year
4.69
from -0.30
EPS Next Year
5.08
from 4.69
Increased by 8.41%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 2.5B | 2.6B | 2.8B |
| Avg | 2.4B | 2.5B | 2.7B |
| Low | 2.3B | 2.4B | 2.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 10.4% | 10.4% | 9.7% |
| Avg | 6.3% | 5.7% | 6.6% |
| Low | 1.1% | 0.7% | 2.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.03 | 5.64 | 4.76 |
| Avg | 4.69 | 5.08 | 4.62 |
| Low | 4.37 | 4.74 | 4.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 20.2% | -6.4% |
| Avg | - | 8.4% | -9.1% |
| Low | - | 1.1% | -12.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.